Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest AssureRx Health Inc. Stories

2013-04-16 08:28:52

Patent Describes Multi-Gene Analysis to Individualize Psychotropic Medication Selection MASON, Ohio and ROCHESTER, Minn., April 16, 2013 /PRNewswire/ -- Mayo Clinic and AssureRx Health, Inc. today announced that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 8,401,801 encompassing "Methods for Selecting Medications" by Mayo inventors Drs. David A. Mrazek, John L. Black, and Dennis J. O'Kane. The Mayo Clinic patent covers the use of multiple...

2013-04-02 16:25:58

MASON, Ohio, April 2, 2013 /PRNewswire/ -- AssureRx Health, Inc. today announced the appointment of Stephen A. Stamp as Senior Vice President & CFO and Jeffrey P. Bush as Vice President, Payer Markets and Reimbursement to its leadership team. The management appointments coincide with increasing demand for GeneSight pharmacogenomic testing services, which support healthcare providers in medication selection and the management of side effects for patients with neuropsychiatric and other...

2013-01-08 08:30:36

MASON, Ohio, Jan. 8, 2013 /PRNewswire/ -- AssureRx Health, Inc. today announced the formation of a Scientific Advisory Board (SAB) to guide research and development of novel pharmacogenomic-based treatment decision support products. The SAB appointments coincide with the Company's increasing emphasis on cutting-edge pharmacogenomic research and new clinical products that support healthcare providers in medication selection for patients with neuropsychiatric and other disorders. "The...

2012-12-11 08:27:19

MASON, Ohio, Dec. 11, 2012 /PRNewswire/ -- AssureRx Health, Inc. today announced four key additions to its leadership team. The management appointments coincide with the need to support increasing GeneSightRx pharmacogenomic testing services, which support healthcare providers in medication selection and the managing of side effects for patients with neuropsychiatric and other disorders. "We continue to experience rapid adoption of our pharmacogenomic treatment support products...

2012-05-30 10:25:11

MASON, Ohio, May 30, 2012 /PRNewswire/ -- AssureRx Health, Inc. today announced the closing of a $12.5 million Series C financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug for individual neuropsychiatric patients, will use the funds to increase commercial activities for its two flagship pharmacogenomic products, GeneSightRx® Psychotropic and GeneSightRx® ADHD, as well as next generation product...

2012-05-07 02:31:48

MASON, Ohio, May 7, 2012 /PRNewswire/ -- AssureRx Health, Inc. today announced it has launched a personalized medicine test for the growing number of children and adults diagnosed with attention deficit hyperactivity disorder (ADHD). The new pharmacogenomic test can assist clinicians with important medication decisions that result from genomic differences in how individual patients tolerate ADHD medications. GeneSightRx ADHD analyzes variations in three genes that influence how a patient...

2012-01-31 07:00:00

MASON, Ohio, Jan. 31, 2012 /PRNewswire/ -- AssureRx Health, Inc., today announced that it has secured an $8 million Term and Revolving Credit Facility that provides additional capital to support increasing clinical adoption of GeneSightRx and to finance multiple new products scheduled for launch in 2012. The credit facilities were secured through the company's new banking partner, Silicon Valley Bank, a premier bank for venture-backed technology companies. The new line of...

2012-01-17 06:00:00

CINCINNATI, Jan. 17, 2012 /PRNewswire/ -- AssureRx Health, Inc., today announced the release of GeneSightRx 1.8, a pharmacogenomic testing program helping behavioral health clinicians select medications for their patients using genetic information, peer-reviewed research and approved drug labeling. The enhancements include the addition of six new psychotropic medications to the current panel of 26 medications, expanded support for mobile devices, and new capabilities to...

2011-09-07 09:08:00

CINCINNATI, Sept. 7, 2011 /PRNewswire/ -- AssureRx Health, Inc., today announced three additions to its senior management team. These additions coincide with increasing adoption of GeneSightRx® pharmacogenetic testing aimed at assisting healthcare providers manage side effects and drug selection for patients requiring antidepressant or antipsychotic medication therapy. "We are encouraged by the rapid adoption and positive feedback from psychiatrists and other prescribers...

2011-05-12 09:00:00

CINCINNATI, May 12, 2011 /PRNewswire/ -- AssureRx Health, Inc., today announced two presentations on the clinical practice of utilizing its pharmacogenetic test, GeneSightRx®, at the 164th Annual Meeting of the American Psychiatric Association (APA) in Honolulu, May 14-18, 2011. Key activities include a free GeneSightRx testing program for the first 200 physicians who visit AssureRx's booth at the conference. Amita Patel, M.D., adult and geriatric psychiatrist at Dayton...